Banner - NPPA Connect
Quiz|Articles|July 19, 2026

Dermatology Times Spot Test: July 19, 2026

Listen
0:00 / 0:00

Key Takeaways

  • A weekly quiz structure is used to assess reader familiarity with foundational topics and evolving dermatology practice areas.
  • This week’s questions are oriented around current dermatology news items from the prior week.
SHOW MORE

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Welcome to Dermatology Times' Spot Test!

Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we’ll focus on the latest news from this week.

Do you have a set of quiz questions to share? Contact editor Marie Bosslett at [email protected] to contribute.

What percentage of patients in the mITT analysis of the SIGNAL-AA phase 2a trial evaluating bempikibart achieved a SALT-20 response at week 36?


When was improvement in female pattern hair loss first observed during the phase 2 open-label study of VDPHL01?


What class of medication is soficitinib (ICP-332), which is currently being evaluated for atopic dermatitis?